Real-world effectiveness and safety of prolonged bedaquiline course in the treatment of drug-resistant tuberculosis—a multi-center retrospective cohort study in a country with a high burden of drug-resistant tuberculosis
ABSTRACT Bedaquiline (BDQ) has gradually become a core drug in drug-resistant tuberculosis (DR-TB) treatment, and the additional benefits of prolonging BDQ use remain unclear. Patients with DR-TB who received a BDQ-containing regimen from three Chinese clinical centers between 1 March 2018 and 31 De...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2025-08-01
|
| シリーズ: | Microbiology Spectrum |
| 主題: | |
| オンライン・アクセス: | https://journals.asm.org/doi/10.1128/spectrum.00097-25 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
